Category: Expert Perspectives in Atopic Dermatitis

Peter Lio, MD, FAAD: Sustainable Improvements for Patients with Atopic Dermatitis
Dr. Lio discusses the effects of topical ruxolitinib in his patients with atopic dermatitis, and how he incorporates this treatment into his practice.
Adam Friedman, MD, FAAD: Matching Patients to the Right Treatments for Atopic Dermatitis​
Dr. Friedman discusses how to evaluate patients with atopic dermatitis to match them with their best treatment as well as the importance of keeping a
Raj Chovatiya, MD, PhD: Itch in Atopic Dermatitis
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses
Raj Chovatiya, MD, PhD: Explaining the Mechanisms and Advantages of JAK Inhibitors
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses
Seemal Desai, MD, FAAD: The Newest JAK Inhibitors for Inflammatory Skin Diseases
Seemai Desai, MD, FAAD, a dermatologist in private and academic practice in Dallas, Texas, discusses the development and use of JAK inhibitors for inflammatory skin
Peter Lio, MD: Innovations in JAK Inhibitors
Peter Lio, MD, of Medical Dermatology Associates of Chicago in Chicago, Illinois, discusses recent innovations in atopic dermatitis therapies with regard to JAK inhibitors. Dr.